Skip to main content
. 2018 Jun 1;40(5):1335–1341. doi: 10.1007/s11096-018-0654-4

Table 3.

Changes from baseline to week 12 in affective symptoms and disability; mean (95% CI) and two-sided p values from Wilcoxon rank sum test for between-group comparisons

EGb 761® Pentoxifylline p value
HADS anxiety score − 1.3 (− 1.82; − 0.85) − 1.1 (− 1.55; − 0.56) 0.2523
HADS depression score − 0.4 (− 0.89; 0.15) − 0.5 (− 0.92; 0.01) 0.5753
SDS global impairment − 0.6 (− 0.90; − 0.28) − 0.6 (− 0.91; − 0.27) 0.9485